“There are some new results and we’re very excited about it,” said Arumugam.
The research project is aimed at developing more effective cancer therapeutics using a combination of synthetic chemistry and biological high throughput screening, read the release. Arumugam’s team is making new chemical compounds with the goal of using them as anti-cancer drugs.
“Combining them together is making an effective hybrid drug,” said Arumugam.
The next step is to test the compound and improve water solubility, which would make it a new drug to be re-studied, read the release. The team also needs to determine whether a receptor needs to be attached in order to target specific cancer cells.
About the Author